[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369039-105":59,"doc-detail-369039-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-of-dtx3l-prognostic-and-immunological-biomarker-study","Pan-cancer analysis of DTX3L - Prognostic and immunological biomarker study","","DTX3L is investigated across pan-cancers to clarify its prognostic and immunological roles and the molecular basis of tumor progression. Expression profiles were analyzed by integrating multiple databases, linking DTX3L levels with clinicopathological features, survival outcomes, and immune infiltration. STRING-based interaction and functional enrichment (GO/KEGG) were used to identify DTX3L-associated genes and pathways, followed by experimental validation. DTX3L knockdown reduced ovarian cancer proliferation and migration and increased apoptosis, supporting its value as a poor-prognosis biomarker and potential therapeutic target for immunotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-dtx3l-prognostic-and-immunological-biomarker-study/369039/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-dtx3l-prognostic-and-immunological-biomarker-study/369039.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study purpose regarding DTX3L in pan-cancer research?","Question",{"text":112,"@type":113},"To systematically examine DTX3L expression profiles, its prognostic value, and potential regulatory mechanisms across different cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were DTX3L expression and its clinical associations analyzed?",{"text":117,"@type":113},"The study integrated data from multiple databases and assessed correlations between DTX3L expression and clinicopathological features, prognosis, and immune infiltration-related measures.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports DTX3L’s functional role in ovarian cancer cells?",{"text":121,"@type":113},"DTX3L knockdown markedly reduced ovarian cancer cell proliferation and migration and increased apoptosis in ovarian cancer cells and tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369039,1790579789,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPan-cancer analysis of DTX3Las a potential prognostic and immunological biomarker  \nYunfeng Zhang1, Jingyi Mu1, Yue Lu1, Jiayu Jing1, Jianmei Huang2, Zhenglong Guo2, WenkeYang2, Guiyu Lou2􀀍 & Yue Wang1􀀍  \nDTX3L plays pivotal roles in diverse biological processes, yet its multifaceted functions and the molecular mechanisms driving tumorigenesis and cancer progression remain incompletely defined. Here, we systematically investigated DTX3L’s expression profiles, prognostic value, and potential regulatory mechanisms across pan-cancers. By integrating data from multiple databases, we analyzed the expression levels of DTX3L and its correlations with clinicopathological features, prognosis, and immune infiltration. Leveraging the STRING database, we identified DTX3L-associated genes and performed functional enrichment analysis. Finally, we experimentally validated the impact of DTX3L knockdown on the proliferation and migration of ovarian cancer cells. We found DTX3L was significantly upregulated in most human tumors, with its expression correlating with patient age, TNM stage, grade, and clinical stage—indicating DTX3L as a biomarker of poor prognosis. DTX3L showed extensive co-expression with key RNA modification genes and correlations with immune checkpoint genes, immune cells, and immune infiltration scores. GO and KEGG analyses linked DTX3Lto DNA damage repair, ubiquitination regulation, and innate immune signaling pathways. In ovarian cancer cells, DTX3L knockdown markedly reduced cell proliferation, migration, and increased apoptosis. These findings demonstrate that DTX3L is upregulated in various cancers and is associated with poor patient prognosis, suggesting its potential as both a prognostic biomarker and a therapeutic target in pan-cancer immunotherapy.  \nKeywords DTX3L, Pan-cancer, Biomarker, Prognosis, Immunotherapy  \nDeltex E3 ubiquitin ligase 3 L (DTX3L), a member of the Deltex family, possesses unique structural features and critical biological functions. Its protein structure includes a C-terminal RING (Really Interesting New Gene) domain and a DTC (Deltex C-Terminal) domain, which are pivotal for mediating interactions with E2 ubiquitinconjugating enzymes and recognizing ubiquitination substrates1,2. At the N-terminus, three subdomains (D1, D2, and D3) are present. The D1 and D2 domains facilitate DTX3L homooligomerization, while the D3 domain binds to PARP9 (poly (ADP-ribose) polymerase 9), forming a high-molecular-weight oligomeric complex essential for cellular signal transduction3,4.  \nAs a key E3 ubiquitin ligase, DTX3L has emerged as a pivotal regulator in cancer biology, with its dysregulation implicated in the oncogenic transformation and progression of multiple malignancies. Over the past decade, cumulative evidence has unveiled context-dependent functions of DTX3L in pancreatic cancer, esophageal squamous cell carcinoma, and glioma, where it orchestrates tumor cell proliferation, migration, and chemoresistance through ubiquitin-mediated proteostasis5–7. Notably, recent studies have highlighted its role in modulating immune checkpoint dynamics and tumor microenvironment remodeling, thereby facilitating immune evasion—a mechanism that underscores its potential as an immunotherapeutic target.  \nPan-cancer analyses have become essential in oncology research, as they enable the identification of common molecular alterations and pathways across diverse cancer types, thereby facilitating the discovery of universal biomarkers and therapeutic targets8,9.Therefore, this study aims to conduct a comprehensive pan-cancer analysis of DTX3L, focusing on its expression patterns, prognostic significance, and mechanistic heterogeneity. The specific objectives include: (1) characterizing DTX3L expression across diverse cancer types using multi-omics  \n1Department of Obstetrics and Gynecology, Zhengzhou University People’s Hospital, Henan Provin","cbCaib6bPXuRRrZV","https://ap.wps.com/l/cbCaib6bPXuRRrZV","pdf",11625369,14,"English","# Introduction\n# Methods\n## DTX3L mRNA and protein expression level analysis\n# Results\n# Discussion\n# Conclusions","[{\"question\":\"What is the study purpose regarding DTX3L in pan-cancer research?\",\"answer\":\"To systematically examine DTX3L expression profiles, its prognostic value, and potential regulatory mechanisms across different cancer types.\"},{\"question\":\"How were DTX3L expression and its clinical associations analyzed?\",\"answer\":\"The study integrated data from multiple databases and assessed correlations between DTX3L expression and clinicopathological features, prognosis, and immune infiltration-related measures.\"},{\"question\":\"What experimental evidence supports DTX3L’s functional role in ovarian cancer cells?\",\"answer\":\"DTX3L knockdown markedly reduced ovarian cancer cell proliferation and migration and increased apoptosis in ovarian cancer cells and tissues.\"}]","Pan-cancer analysis of DTX3L - Prognostic and immunological biomarker study | PDF",1790180306,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32a8bf3121f9f9952a9f70383909cd40.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/681905249f77454e9292ca98c0f822b2.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3e057da775f7a590c87a65d8654a9b6.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3329d2ff625919abb75e90a107b69be5.webp",980,1287]